Robert Huizinga

Biography

Rob has more than 24 years of clinical research experience. He has managed the global clinical development of voclosporin since 2002 where he was with Isotechnika Pharma, Inc prior to its merger with Aurinia in 2013. Before joining Isotechnika, Rob was an Investigator in nephrology and transplantation clinical trials where he was involved in more than 60 clinical trials from Phase I through Phase IV and the successful development of numerous compounds. He has acted as a consultant to nephrology and transplantation pharmaceutical companies and has lectured extensively. Over the years, Rob has established and nurtured close relationships in the nephrology and transplant communities and has fostered strong connections with both investigators and clinical trial sites.

Research Interest

Clinical Research